Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program endorsed by ISBER. This testing program is an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods. The Radboud Biobank participated in the program for viable PBMC isolation and the program for cell free DNA Extraction from whole blood. Stabilized whole blood received from IBBL was processed by the Radboud Laboratory for Diagnostics by our standard procedure followed by the cfDNA extraction performed by the Genetics department. The PBMCs were isolated from donor blood by the Laboratory of Medical Immunology with the AutoMACS.
DNA and PBMCs where sent back to IBBL for the analysis. Recently we received the reports of the Proficiency tests which resulted in a quality certificate for both methods. The participants’ mean (n=11 cfDNA and n=53 PBMC) is considered as the assigned value and basic statistics were performed.
If you are interested in the methods or report in more detail, please contact the Radboud Biobank.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Radboud Biobank Office Relocation
30 January 2025We would like to inform you about the upcoming relocation of the Radboud Biobank office.
read more
Request for DNA samples from stored whole blood and/or saliva
30 January 2025There are biobank collections that collected whole blood and saliva before joining the Radboud Biobank to isolate DNA from them later.
read more
Great news!
30 January 2025We have good news for both new and existing collections and projects interested in isolating PBMCs (Peripheral Blood Mononuclear Cells)!
read more
BBMRI-ERIC launches 10-Year Roadmap: Biobanking for a Healthier World
30 January 2025BBMRI-ERIC, the European research infrastructure for biobanking and biomolecular resources, has launched its visionary 10-Year Roadmap (2025-2035).
read more
New business model for the Radboud Biobank
24 November 2024The Radboudumc Board of Directors decided, after receiving advice from the UMC council, to change the Radboud Biobank business model.
read more